|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MLYS | Rodman David Malcom | Chief Medical Officer | Apr 11 | Option Exercise | 0.54 | 5,017 | 2,709 | 60,648 | Apr 15 04:24 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Apr 12 | Option Exercise | 1.08 | 6,349 | 6,857 | 66,997 | Apr 15 04:24 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Mar 11 | Option Exercise | 0.54 | 5,017 | 2,709 | 49,283 | Mar 13 05:35 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Mar 12 | Option Exercise | 1.08 | 6,348 | 6,856 | 55,631 | Mar 13 05:35 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Feb 12 | Option Exercise | 0.84 | 11,366 | 9,566 | 44,266 | Feb 13 04:08 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Jan 11 | Option Exercise | 0.54 | 5,017 | 2,709 | 26,552 | Jan 12 04:01 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Jan 12 | Option Exercise | 1.08 | 6,348 | 6,856 | 32,900 | Jan 12 04:01 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Dec 11 | Option Exercise | 0.54 | 5,018 | 2,710 | 20,069 | Dec 12 05:08 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Nov 13 | Option Exercise | 0.54 | 5,017 | 2,709 | 15,051 | Nov 14 06:18 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Nov 03 | Option Exercise | 0.54 | 10,034 | 5,418 | 10,034 | Nov 07 05:15 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Aug 10 | Option Exercise | 0.54 | 74,625 | 40,298 | 74,625 | Aug 11 07:11 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Aug 11 | Option Exercise | 0.80 | 157,091 | 125,967 | 80,909 | Aug 11 07:11 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Aug 11 | Sale | 12.81 | 157,091 | 2,012,336 | 0 | Aug 11 07:11 PM |
MLYS | Rodman David Malcom | Chief Medical Officer | Aug 10 | Sale | 13.16 | 74,625 | 982,065 | 0 | Aug 11 07:11 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite